Collaboration Details

Title of Collaborative Activity:

World Health Organization Pediatric Antiretroviral Drug Optimization (PADO)

Description of Collaborative Activity:

WHO-led drug optimization activities are designed to promote broad access to more efficacious, safer and more tolerable antiretroviral (ARV) regimens in optimal formulations for adults, adolescents, children, and pregnant and lactating women.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

NIH Participating Institutes/Centers/Office of the Director:

NICHD

HHS Agency Collaborators on this Activity:

CDC, FDA